Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02371798

Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?

Diagnosing Endolymphatic Hydrops in Patients With Meniere Disease Using Magnetic Resonance Imaging With Intravenous Gadolinium Administration

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to see if magnetic resonance imaging (MRI) with a double dose of contrast, or dye, and delayed imaging with MRI can help to diagnose Meniere Disease.

Detailed description

Meniere's disease (MD) is a medical condition causing attacks of vertigo, ringing in the ears, hearing loss and often a fullness in the ear. Currently there is no definitive test to diagnose the problem. It is believed to be caused by inner ear abnormalities, specifically of an over-collection of lymphatic fluid.The goal of this trial is to determine if an MRI with double dose of IV gadolinium can be diagnostic.

Conditions

Interventions

TypeNameDescription
DRUGGadopentetate dimeglumineIV administration of 0.2 mmol/kg of Gd-DTPA

Timeline

Start date
2015-02-01
Primary completion
2016-11-01
Completion
2016-11-01
First posted
2015-02-26
Last updated
2016-12-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02371798. Inclusion in this directory is not an endorsement.